| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.075 | 0.3 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.3 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.32 | 0.3 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |